"Killer acquisitions" is to acquire innovative targets solely to discontinue the target’s innovation projects and preempt future competition.
Is the takeover of Resapp Health Ltd pegged for a killer acquisition?
We know that:
- ResappDx technology works, that is, CE Marked in Europe and TGA approved in Australia.
- There is potential for this technology to stop the misuse/overuse of antibiotics caused by misdiagnoses.
- Pfizer is one of the forerunners in the Antibiotics Market, which is projected to grow from $38.08 billion in 2021 to $45.30 billion in 2028.
- Researchers estimate that 7% of the acquisitions in the pharmaceutical industry are "killer acquisitions".
In addition, the overuse of antibiotics not only affects: people's health outcomes; but other systems as well.
Furthermore, the database of pre-covid cough sounds RAP has recorded, is a resource that can never be duplicated/reproduced.
